Case Study: Reimbursement & Market Access — Supporting Products with Required Imaging
How a manufacturer integrated imaging requirements into its access and patient support strategy.
Case Study: Leveraging Payer Insights to Shape Market Access Strategies and Tactics
How payer research helped refine value messaging, pricing strategy, and evidence plans.
Case Study: Preparing and Executing a Comprehensive 340B Contract Pharmacy Strategy
How a pharmaceutical company built a compliant, scalable 340B contract pharmacy program.
Why Real-World Evidence Is Reshaping the Economics of Drug Pricing
Real-world evidence is no longer just a regulatory checkbox—it’s a strategic driver of pricing, access, and payer engagement. Discover how leading life sciences teams are embedding RWE earlier to shape reimbursement strategy, optimize launch planning, and unlock value-based contracts.
Deal-Driven Policy, Direct-to-Patient Models, and State Momentum: Preparing for 2026
As policy dynamics accelerate across federal and state channels, manufacturers must prepare for multiple scenarios and align internal planning. Key readiness priorities for 2026.
Case Study: Strategic Coding Application Creates a Reimbursement Pathway for a Device Accessory
See how a smarter coding strategy helped a medical device company strengthen payer alignment and accelerate access.
2026 Outlook on the Management of Drug Price Negotiation Program and Competitor Drugs
Magnolia Market Access released its fifth iteration of the IRA Payer Insights Survey in the summer of 2025 to understand how the IRA will affect the Medicare Part D program, including beneficiary premiums, formulary coverage, and contract negotiations for manufacturers and payers.
Payer Research: A Strategic Driver of ROI Across the Lifecycle
Design research payers can use: focus on real-world outcomes, durability, and total cost of care; bring payer input in early and often; and pressure-test access levers pre-launch. Turn strong science into coverage, reimbursement, and measurable ROI.
Case Study: Using a Formulary Databook to Navigate 2025’s Medicare Part D Shifts
Find out how one manufacturer turned formulary complexity and policy uncertainty into strategic advantage using Magnolia Market Access’ Part D Formulary Databook.
Using Data-Driven Coverage Assessments to Unlock Medicare Part D Formulary Intelligence
As Medicare Part D plans adopt stricter utilization management, raise cost-sharing, and adjust tier placements, manufacturers face growing challenges in maintaining access. A data-driven formulary coverage assessment helps teams evaluate product positioning, benchmark competitors, and prepare for policy impacts — turning complexity into actionable strategy.